5,353 findings · Hormonal · published 2017+
- HormonalGood
Male obesity causes male subfertility through hormonal imbalance (hypogonadism), chronic inflammation, oxidative stress, and increased scrotal temperature, leading to reduced sperm quality and DNA damage.
If you are overweight or obese, your fertility may be compromised due to hormonal changes, inflammation, and heat stress on the testes. Losing weight through lifestyle changes or surgery can improve testosterone levels and sperm count, suggesting that weight management is a critical step for men trying to conceive.
Supports 2017 - HormonalGood
Performing 60 minutes of moderate-intensity treadmill exercise induces significant circadian phase shifts in humans, with large phase delays occurring when exercise is performed between 7:00 pm and 10:00 pm, and large phase advances occurring when exercise is performed at 7:00 am or between 1:00 pm and 4:00 pm.
If you need to adjust your sleep schedule, time your 60-minute moderate exercise (where you can talk but not sing) strategically. To fall asleep earlier (phase advance), exercise between 7:00 am and 4:00 pm. To stay up later (phase delay), exercise between 7:00 pm and 10:00 pm. Avoid exercising around 4:00 pm or 2:00 am if you want to minimize shifts, as these times produce minimal effects.
Supports 2019 - HormonalGood
Type 2 diabetes mellitus (T2DM) acts as an independent pathogenic factor for osteoarthritis (OA) progression and arthroplasty complications through mechanisms of oxidative stress, advanced glycation end-products (AGEs), and insulin resistance, separate from mechanical load.
If you have Type 2 Diabetes and joint pain, treating the diabetes is part of treating the arthritis. High blood sugar and insulin resistance actively damage joint tissue through inflammation and stiffness (AGEs), independent of how much you weigh. Optimize glucose control to potentially slow joint degradation.
Supports 2019 - HormonalGood
Hyperinsulinemia promotes obesity by inhibiting lipolysis and promoting lipogenesis at insulin concentrations lower than those required to inhibit gluconeogenesis.
Focus on keeping your fasting insulin low to prevent fat gain. Even modest increases in insulin (e.g., from doubling your baseline) can shut down fat burning (lipolysis) and start fat storage (lipogenesis) before your blood sugar regulation is even affected. This suggests that frequent snacking or high-carb meals, which keep insulin elevated, are more likely to cause weight gain than occasional high-sugar meals that spike glucose but clear quickly.
Supports 2020 - HormonalGood
Testosterone administration increases muscle power and function, but its use is limited by potential side effects, particularly cardiovascular events and prostate malignancy risk, which vary by administration route.
Testosterone can improve muscle power and function, but it is not a first-line treatment due to potential side effects. If considered, the route of administration matters: oral testosterone may carry higher cardiovascular risks compared to transdermal or injection methods. Consult a physician to weigh benefits against risks.
Qualifies 2017 - HormonalGood
Small increases in skin temperature (0.4°C within the 31-35°C range) can shorten sleep latency and promote deeper sleep without altering core body temperature.
You do not need to significantly heat your room or body to fall asleep faster. A subtle warming of your skin (via bedding) by just 0.4°C is sufficient to shorten sleep latency. This is particularly useful for elderly individuals or insomniacs who may have deficits in normal thermoregulation.
Supports 2019 - HormonalGood
Sarcopenic obesity drives cardiovascular disease and mortality through mechanisms of chronic low-grade inflammation, insulin resistance, and lipotoxicity, creating a vicious cycle with cardiovascular conditions.
Understanding that fat and muscle loss interact to cause inflammation and heart risk highlights why treating both is crucial. Managing inflammation and insulin sensitivity through lifestyle can break this cycle.
Supports 2023 - HormonalGood
Obesity causes a significant reduction in circulating adiponectin levels, which contributes to insulin resistance, metabolic syndrome, and increased cancer risk.
If you have excess body fat, your body naturally produces less of this protective hormone, which makes you more resistant to insulin and prone to inflammation. This is a biological feedback loop, not a character flaw. Addressing the underlying adiposity through sustainable lifestyle changes can help restore normal adiponectin levels and improve metabolic health.
Supports 2019 - HormonalGood
High DHA fish oil supplementation (DHA > EPA) improves cardiovascular efficiency during submaximal exercise by lowering heart rate and improving heart rate variability, without negatively affecting endurance performance.
If you are looking to improve cardiovascular efficiency during moderate exercise, high DHA fish oil (where DHA exceeds EPA) may help lower your heart rate for a given workload. This does not necessarily make you faster (endurance performance was unaffected in some studies), but it may make exercise feel easier by reducing cardiac strain. Look for supplements with a DHA:EPA ratio greater than 1:1, dosed between 1-6g daily.
Supports 2018 - HormonalGood
High DHA fish oil supplementation improves postprandial arterial stiffness and endothelial function, potentially reducing cardiovascular disease risk, whereas EPA alone may not provide the same postprandial benefit.
To support vascular health and reduce arterial stiffness after meals, choose a high DHA fish oil supplement (where DHA is higher than EPA). This may improve how your arteries handle the stress of a fatty meal. Standard fish oils with higher EPA may not offer this specific post-meal vascular benefit.
Supports 2018 - HormonalGood
Consuming 1 cup (150g) of blueberries daily for 6 months improves endothelial function and reduces arterial stiffness in adults with metabolic syndrome, independent of changes in insulin resistance.
If you have metabolic syndrome, eating one cup of blueberries every day for six months can improve your blood vessel health and stiffness, which lowers cardiovascular risk. However, this amount of blueberries will not improve your insulin resistance or blood sugar control, so it should be part of a broader strategy that includes managing insulin sensitivity.
Qualifies 2018 - HormonalGood
In statin non-users with metabolic syndrome, consuming 1 cup of blueberries daily for 6 months significantly increases HDL cholesterol, HDL particle number, and apolipoprotein A-I levels.
If you have metabolic syndrome and are not taking statins, eating one cup of blueberries daily for six months may improve your HDL cholesterol and particle numbers. This benefit was not observed in those taking statins, suggesting medication may interfere with this specific dietary effect.
Qualifies 2018 - HormonalGood
Post-menopausal women exhibit 'anabolic resistance' to bone-loading exercise due to estrogen depletion, resulting in negligible increases in bone mass, although exercise can still preserve bone strength and mitigate loss.
If you are post-menopausal, do not expect exercise to significantly increase your bone density due to hormonal changes. However, continue weight-bearing and resistance exercise to maintain bone strength, improve balance, and reduce fracture risk. Focus on preservation and strength rather than mass gain.
Qualifies 2017 - HormonalGood
Continuous Glucose Monitoring (CGM) metrics, specifically Time in Range (TIR) and Glycemic Variability (GV), provide superior clinical insight and safety compared to HbA1c alone by detecting hypoglycemia and glucose excursions that HbA1c misses.
If you have diabetes, rely on CGM data (Time in Range) alongside HbA1c. HbA1c tells you the average, but CGM shows the dangerous swings and lows that average numbers hide. Use this data to adjust diet and medication to stay in the 70-180 mg/dL range as much as possible.
Qualifies 2019 - HormonalGood
Newer glucose-lowering agents (ultra-long-acting insulin analogs, SGLT2 inhibitors, GLP-1 RAs) reduce Glycemic Variability (GV) and hypoglycemia risk compared to older agents (e.g., insulin glargine 100U/mL) due to smoother pharmacodynamic profiles.
If you experience high glucose swings or frequent lows on older insulin, discuss switching to newer analogs (like Degludec or Glargine 300U) or adding SGLT2/GLP-1 agents with your doctor. These drugs are designed to work more smoothly, reducing dangerous lows and glucose spikes.
Supports 2019 - HormonalGood
Glycemic Variability (GV), defined by a coefficient of variation (CV) >36%, is independently associated with an increased risk of hypoglycemia and diabetes-related complications, regardless of HbA1c levels.
Monitor your Glucose Coefficient of Variation (CV). If your CV is above 36%, your glucose is swinging too much, which increases complication risk. Work with your doctor to smooth out these swings using diet, exercise, or medication adjustments, even if your HbA1c looks okay.
Supports 2019 - HormonalGood
Sleep restriction (SR) increases energy intake by 300–550 kcal/day and alters hormonal signaling (increased ghrelin, decreased leptin, reduced GLP-1) and brain reward network activity, leading to a positive energy balance and weight gain.
If you are struggling to lose weight or control your appetite, check your sleep duration. Getting less than 7 hours of sleep can significantly increase your hunger hormones and drive you to eat more calories, particularly from high-fat and high-carb foods. Prioritizing 7-8 hours of sleep is a critical, often overlooked, component of any weight loss strategy.
Supports 2017 - HormonalGood
Once-weekly semaglutide (1.0 mg) and once-daily liraglutide (up to 1.8 mg) significantly reduce albuminuria and slow the decline of estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes, with effects being more pronounced in patients with preexisting chronic kidney disease (eGFR <60 mL/min/1.73 m2).
If you have type 2 diabetes, especially if you have early signs of kidney stress (like reduced eGFR or albuminuria), GLP-1 receptor agonists like semaglutide (once weekly) or liraglutide (once daily) can protect your kidneys. They reduce protein in the urine (albuminuria) and slow the loss of kidney function over time. This benefit is particularly strong if your kidney function is already reduced (eGFR <60). Discuss these options with your doctor, as they may offer kidney protection beyond just blood sugar control.
Supports 2021 - HormonalGood
Obesity is strongly associated with increased oxidative stress, chronic low-grade inflammation, and an increased risk of severe outcomes in infectious diseases like COVID-19.
Maintaining a healthy weight is critical not just for metabolic health but also for reducing the risk of severe complications from respiratory infections like COVID-19. Obesity is a major predictor of severe symptoms and critical care admission.
Supports 2021 - HormonalGood
Oral ingestion of capsinoids (non-pungent capsaicin analogs) increases whole-body energy expenditure and reduces abdominal fat in humans with metabolically active brown adipose tissue (BAT) through the activation of the TRPV1-SNS-BAT axis.
If you have detectable brown fat, taking capsinoids (6-9 mg daily) may help slightly reduce abdominal fat and increase energy expenditure. However, if you do not have active brown fat, this supplement will likely have no effect on your metabolism. It is safe for long-term use.
Conditional 2020 - HormonalGood
Green tea extract rich in catechins increases energy expenditure and reduces body fat in humans with higher brown adipose tissue (BAT) activities, likely through the activation of TRPV1/TRPA1 channels rather than COMT inhibition.
Drinking green tea extract rich in catechins daily may slightly reduce body fat (2-3%) if you have active brown fat. The benefit comes from the catechins, not just the caffeine. It is not a magic bullet and requires existing BAT activity to work.
Conditional 2020 - HormonalGood
Increased body adiposity, specifically higher BMI and adult weight gain, significantly increases the risk of breast cancer in postmenopausal women, particularly for hormone receptor-positive (HR+) tumors.
Maintain a healthy body weight and avoid adult weight gain to reduce breast cancer risk after menopause. This is especially important for preventing hormone receptor-positive breast cancers.
Supports 2019 - HormonalGood
Attenuated (slow) heart rate recovery (HRR) after exercise is associated with a significantly increased risk of cardiovascular events and all-cause mortality in the general population.
To assess your long-term cardiovascular risk, measure your heart rate immediately after stopping moderate-to-vigorous exercise and again after 1 or 2 minutes. A smaller drop (attenuated HRR) indicates slower autonomic recovery and is linked to higher mortality risk. This is a simple, non-invasive metric you can track with any basic heart rate monitor to gauge your autonomic health and longevity risk, independent of your weight or blood pressure.
Supports 2017 - HormonalGood
For every 10 beats per minute (bpm) decrement in heart rate recovery, the risk of cardiovascular events increases by 13% and all-cause mortality by 9%.
Your heart rate recovery speed matters incrementally. Each 10 bpm drop in your heart rate during the first 1-2 minutes after exercise is associated with a 9-13% reduction in your risk of death or heart disease. Improving this recovery speed through consistent aerobic training is a direct lever for longevity.
Supports 2017